TACSTD2 and ovarian carcinoma: Trophoblast cell-surface antigen 2 (TROP2)-CAR-NK cells engineered with IL-15 and delivered intraperitoneally are under study for platinum-resistant ovarian cancer [195] (ClinicalTrials.gov identifier: NCT05922930).